Navigation Links
Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimer's Disease
Date:7/17/2008

the Alzheimer's Disease and Memory Disorders Center, Baylor College of Medicine in Houston. "There is a clear need for new treatments that can add value and enduring benefit to the treatment of Alzheimer's disease. The results of this trial suggest that, if the findings are replicated, Dimebon could advance Alzheimer's treatment, offering more hope for patients and their caregivers."

Dimebon was well-tolerated throughout the trial. There was no difference between the Dimebon and placebo groups in the number of patients with adverse events, and the most common side effects seen were dry mouth (18 percent versus 1 percent for placebo) and depressed mood/depression (15 percent versus 5 percent for placebo). Importantly, fewer patients treated with Dimebon had serious adverse events than did patients on placebo at the end of the study (3 percent versus 12 percent; p=0.03).

Additional analyses of the Dimebon pivotal study data presented at recent medical conferences showed that Dimebon's impact extended to caregivers. Behavioral improvements in Dimebon-treated patients resulted in a significant decrease in caregiver distress at six months and at one year compared to the distress of caregivers of placebo-treated patients. Further, after six months, caregivers of Dimebon-treated patients saved approximately one hour per day assisting patients with activities of daily living compared to caregivers of placebo-treated patients.

"The magnitude, consistency and duration of the beneficial effects of Dimebon demonstrated in this trial are striking," said Paul Aisen, M.D., Director, Alzheimer's Disease Cooperative Study (ADCS) and Professor in the Department of Neurosciences, University of California, San Diego (UCSD). "In addition, the drug has been well-tolerated to date and, if the safety profile is replicated in the ongoing international trial, it will be a substantial advance for this patient population prone to drug side effects."

"We are pleased
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
2. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
3. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
4. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting
5. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
6. Medivations Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year
7. Medivations Dimebon(TM) Significantly Improved Daily Function in Alzheimers Disease Patients, Resulting in Reduced Need for Caregiver Assistance
8. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
9. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
10. Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
11. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Pa. , June 30, 2015 Zynerba Pharmaceuticals, ... on Form S-1 with the U.S. Securities and Exchange Commission ... common stock. The number of shares to be offered and ... determined. Jefferies LLC and Piper Jaffray ... offering, and Canaccord Genuity Inc. and Oppenheimer & Co. Inc. ...
(Date:6/30/2015)... , June 30, 2015 Dipexium Pharmaceuticals, ... pharmaceutical company focused on the development and commercialization ... closing of its previously announced underwritten public offering ... also exercised their over-allotment option in full to ... The net proceeds to Dipexium are ...
(Date:6/30/2015)... VALLEY, Pa. , June 30, 2015 /PRNewswire/ ... and delivering innovative solutions for medical and surgical ... is guaranteeing next-day replacements for surgical equipment at ... product manufacturer to offer this type of guarantee. ... Olympus Full Service Agreement earlier this year. ...
Breaking Medicine Technology:Zynerba Files Registration Statement for Proposed Initial Public Offering of Common Stock 2Dipexium Announces Closing of Public Offering of Common Stock 2Dipexium Announces Closing of Public Offering of Common Stock 3Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3
(Date:7/1/2015)... ... July 01, 2015 , ... The executive ... and marketing of a number of nutritional and beauty products, announced the company ... ECRM Diet, Vitamin & Sports Nutrition conference in Tampa, Florida. This specific ECRM ...
(Date:7/1/2015)... ... 01, 2015 , ... Nutritional Products International, a brand focused on the global ... the 2015 ECRM Diet, Vitamin & Sports Nutrition conference in Tampa, Florida, where it ... ECRM trade show allows companies the chance to meet with a variety of the ...
(Date:7/1/2015)... NV (PRWEB) , ... July 01, 2015 , ... ... be showcasing the newly launched Patient Self-Management (PSM) Solutions at the Society for ... that has been in use for over 10 years, can reduce overall cost ...
(Date:6/30/2015)... ... 01, 2015 , ... Avid boxing style rock concert poster collector, Andrew Hawley ... posters. The Who and the Rascals also played at this concert in New York ... played with the Who backing them up. The Doors gave a very stirring performance ...
(Date:6/30/2015)... ... July 01, 2015 , ... ... responsive and easy to navigate. By making fundamental changes to the UI, the ... from the site said, “Finding the right website has been getting tougher. People ...
Breaking Medicine News(10 mins):Health News:NPI Executives Report Great Success at ECRM Conference 2Health News:NPI Meets With Top Retail Figures at ECRM Conference 2Health News:APhA Foundation to Showcase Newly Introduced Patient Self-Management Solutions at the Society for Human Resource Management (SHRM) Annual Conference and Exposition 2Health News:Avid Boxing Style Rock Concert Poster Collector From Vintage Rock Posters Announces Search for 1968 Doors and Jimi Hendrix Singer Bowl Concert Posters 2Health News:HerpesDatingSites.org Introduces a New Responsive Design 2
... MONDAY, Nov. 15 (HealthDay News) -- People who wear multifocal ... who wear glasses, a new study finds. Multifocal lenses ... common with age. This study included 11 volunteers, aged ... track at night. Wearing multifocal contact lenses resulted ...
... on gaming and health in adolescents, conducted by researchers ... differences linked to gaming as well as important health ... journal Pediatrics , the study is among the ... gaming and problematic gaming in a community sample of ...
... is approximately 40 percent and show no sign of ... to tackle the problem using a comprehensive and pioneering ... partnerships with the Cleveland Metropolitan School District (CMSD) and ... National Institutes of Health (NIH)-funded program will be led ...
... world,s first remote heart procedure, using a robotic arm alongside ... in Leicester. It comes six months after Dr ... procedure using the Amigo Robotic Catheter System. Dr ... consultant cardiologist and electrophysiologist at Glenfield Hospital. On ...
... , MONDAY, Nov. 15 (HealthDay News) -- Although automated external ... in public places such as restaurants, malls and airplanes, they ... of death when used in hospitals, a new study suggests. ... of heart rhythms associated with the heart attack, said researchers ...
... with the cardiac diagnostic imaging technique of myocardial perfusion imaging ... high cumulative estimated radiation dose, according to a study in ... is being released early online because it is being presented ... medical imaging has grown rapidly in recent years, but along ...
Cached Medicine News:Health News:When video games get problematic so do smoking, drug use and aggression 2Health News:Community rallies to fight obesity in Cleveland's urban youth 2Health News:Community rallies to fight obesity in Cleveland's urban youth 3Health News:Community rallies to fight obesity in Cleveland's urban youth 4Health News:Robo-op marks new world first for heart procedure 2Health News:External Defibrillators Not Much Help in Hospitals 2Health News:External Defibrillators Not Much Help in Hospitals 3Health News:Common for patients to undergo multiple cardiac imaging tests, with high cumulative radiation dose 2Health News:Common for patients to undergo multiple cardiac imaging tests, with high cumulative radiation dose 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: